EMJ GOLD

While technology advances and mindsets shift, will there be space and demand for the role of the pharma sales reps in future?

The Japanese pharma industry has many intricacies, so how can companies navigate the ups and downs?

Daiichi Sankyo’s Mary Pinder-Schenck speaks about the evolution she has witnessed in oncology throughout her career and what she predicts for the future of the field.

A new review has outlined 20 recommendations for how the UK can become a world leader in cannabinoid innovation. But is it possible?

The pharmaceutical industry has been trying to refine, reduce and replace animal testing for some time, but animal rights activists argue progress is too incremental.

The overturning of Roe v. Wade is impacting access to medical abortion, but in what ways is pharma trying to help?

Two US pricing experts dissect the implications of The Inflation Reduction for the pharma industry in this roundtable.

Landmark science has led to an inundation of new transformative therapies, but is the cell and gene market at the point of saturation?